A prospective randomized controlled study of the safty of phototherapy using green LED for neonatal hyperbilirubinemia

A prospective randomized controlled study of the safty of phototherapy using green LED for neonatal hyperbilirubinemia - Green LED phototherapy study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039677

Enrollment

Registered

2020-03-03

Start date

2020-03-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal hyperbilirubinemia

Interventions

Green LED phototherapy Blue LED phototherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Newborns with neonatal hyperbilirubinemia who needs phototherapy, whose birth weight is grater than 2200g and gestational age at birth is grater than 36 weeks

Exclusion criteria

Exclusion criteria: Newborns with chromosomal anomaly, multiple congenital anomaly, early onset jaundice, cholestasis,severe birth asphyxia, and those who were judged inappropriate by the principal investigator

Design outcomes

Primary

Measure	Time frame
The extent of DNA damage with the comet assay	—

Secondary

Measure	Time frame
Reduction in total serum bilirubin levels/Production of photoisomer/Rebound of bilirubin total serum bilirubin	—

Countries

Japan

Contacts

Public ContactTakaaki Sadamura

Shikoku Medical Center for Children and Adults Neonatology

volttt2000@gmail.com0877-62-1000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026